{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T09:53:28Z","timestamp":1794563608565,"version":"4.9.1"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Circulation"],"published-print":{"date-parts":[[2004,2,17]]},"abstract":"<jats:p>\n                    <jats:bold>\n                      <jats:italic>Background\u2014<\/jats:italic>\n                    <\/jats:bold>\n                    The US Food and Drug Administration recently issued a warning of subacute thrombosis and hypersensitivity reactions to sirolimus-eluting stents (Cypher). The cause and incidence of these events have not been determined.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>\n                      <jats:italic>Methods and Results\u2014<\/jats:italic>\n                    <\/jats:bold>\n                    We present findings of a 58-year-old man who died of late stent thrombosis 18 months after receiving 2 Cypher stents for unstable angina. Although angiographic and intravascular ultrasound results at 8 months demonstrated the absence of neointimal formation, vessel enlargement was present. An autopsy showed aneurysmal dilation of the stented arterial segments with a severe localized hypersensitivity reaction consisting predominantly of T lymphocytes and eosinophils.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>\n                      <jats:italic>Conclusions\u2014<\/jats:italic>\n                    <\/jats:bold>\n                    The known pharmacokinetic elution profile of Cypher stents and the presence of polymer fragments surrounded by giant cells and eosinophils suggest that a reaction to the polymer may have caused late stent thrombosis. Careful long-term follow-up of patients with vessel enlargement after Cypher stent placement is recommended.\n                  <\/jats:p>","DOI":"10.1161\/01.cir.0000116202.41966.d4","type":"journal-article","created":{"date-parts":[[2004,1,26]],"date-time":"2004-01-26T20:13:33Z","timestamp":1075148013000},"page":"701-705","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1242,"title":["Localized Hypersensitivity and Late Coronary Thrombosis Secondary to a Sirolimus-Eluting Stent"],"prefix":"10.1161","volume":"109","author":[{"given":"Renu","family":"Virmani","sequence":"first","affiliation":[{"name":"From the Department of Cardiovascular Pathology, Armed Forces Institute of Pathology, Washington, DC (R.V., A.F., F.D.K.), and the Cardiovascular (G.G., G.M., N.G., L.M., M.T., O.V.) and Pathology (T.M.) Departments, Ospedali Riuniti di Bergamo, Bergamo, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Guagliumi","sequence":"additional","affiliation":[{"name":"From the Department of Cardiovascular Pathology, Armed Forces Institute of Pathology, Washington, DC (R.V., A.F., F.D.K.), and the Cardiovascular (G.G., G.M., N.G., L.M., M.T., O.V.) and Pathology (T.M.) Departments, Ospedali Riuniti di Bergamo, Bergamo, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Farb","sequence":"additional","affiliation":[{"name":"From the Department of Cardiovascular Pathology, Armed Forces Institute of Pathology, Washington, DC (R.V., A.F., F.D.K.), and the Cardiovascular (G.G., G.M., N.G., L.M., M.T., O.V.) and Pathology (T.M.) Departments, Ospedali Riuniti di Bergamo, Bergamo, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Musumeci","sequence":"additional","affiliation":[{"name":"From the Department of Cardiovascular Pathology, Armed Forces Institute of Pathology, Washington, DC (R.V., A.F., F.D.K.), and the Cardiovascular (G.G., G.M., N.G., L.M., M.T., O.V.) and Pathology (T.M.) Departments, Ospedali Riuniti di Bergamo, Bergamo, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niccolo","family":"Grieco","sequence":"additional","affiliation":[{"name":"From the Department of Cardiovascular Pathology, Armed Forces Institute of Pathology, Washington, DC (R.V., A.F., F.D.K.), and the Cardiovascular (G.G., G.M., N.G., L.M., M.T., O.V.) and Pathology (T.M.) Departments, Ospedali Riuniti di Bergamo, Bergamo, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresio","family":"Motta","sequence":"additional","affiliation":[{"name":"From the Department of Cardiovascular Pathology, Armed Forces Institute of Pathology, Washington, DC (R.V., A.F., F.D.K.), and the Cardiovascular (G.G., G.M., N.G., L.M., M.T., O.V.) and Pathology (T.M.) Departments, Ospedali Riuniti di Bergamo, Bergamo, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurian","family":"Mihalcsik","sequence":"additional","affiliation":[{"name":"From the Department of Cardiovascular Pathology, Armed Forces Institute of Pathology, Washington, DC (R.V., A.F., F.D.K.), and the Cardiovascular (G.G., G.M., N.G., L.M., M.T., O.V.) and Pathology (T.M.) Departments, Ospedali Riuniti di Bergamo, Bergamo, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Tespili","sequence":"additional","affiliation":[{"name":"From the Department of Cardiovascular Pathology, Armed Forces Institute of Pathology, Washington, DC (R.V., A.F., F.D.K.), and the Cardiovascular (G.G., G.M., N.G., L.M., M.T., O.V.) and Pathology (T.M.) Departments, Ospedali Riuniti di Bergamo, Bergamo, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orazio","family":"Valsecchi","sequence":"additional","affiliation":[{"name":"From the Department of Cardiovascular Pathology, Armed Forces Institute of Pathology, Washington, DC (R.V., A.F., F.D.K.), and the Cardiovascular (G.G., G.M., N.G., L.M., M.T., O.V.) and Pathology (T.M.) Departments, Ospedali Riuniti di Bergamo, Bergamo, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank D.","family":"Kolodgie","sequence":"additional","affiliation":[{"name":"From the Department of Cardiovascular Pathology, Armed Forces Institute of Pathology, Washington, DC (R.V., A.F., F.D.K.), and the Cardiovascular (G.G., G.M., N.G., L.M., M.T., O.V.) and Pathology (T.M.) Departments, Ospedali Riuniti di Bergamo, Bergamo, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_2_1_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.103.2.192"},{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.104.10.1188"},{"key":"e_1_3_2_3_2","unstructured":"FDA advises physicians of adverse events associated with Cordis Cypher coronary stents. US Food and Drug Administration Public Health Web Notification. October 29 2003;T03\u2013T71."},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa012843"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14462-5"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa035071"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000051720.59095.6d"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000069330.41022.90"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000069331.67148.2f"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)03262-1"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000019071.72887.bd"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000091115.05480.b0"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/00019501-200205000-00008"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200209150-00025"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01972746"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000066282.05411.17"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0041-1345(03)00213-6"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1875-595X.2003.tb00736.x"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8561(02)00079-6"},{"key":"e_1_3_2_20_2","first-page":"372","volume":"57","year":"2002","journal-title":"SADJ"},{"key":"e_1_3_2_21_2","first-page":"145","volume":"3","year":"1998","journal-title":"Semin Interv Cardiol"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.94.7.1690"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1097\/00019501-199407000-00006"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0142-9612(97)00118-X"},{"key":"e_1_3_2_25_2","first-page":"609","volume":"35","year":"1985","journal-title":"Lab Anim Sci"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/00019501-199901000-00002"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000025585.63486.59"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000103666.25660.77"},{"key":"e_1_3_2_29_2","unstructured":"Leon  MB Abizaid  A Moses  JW.  Subgroup analysis from the Cypher clinical trials. In:  The Cypher Stent: A New Gold Standard in the Treatment of Coronary Artery Disease.  New York NY:  Cardiovascular Research Foundation;  2003:  54\u201357."},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000074778.46065.24"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.282.5397.2261"}],"container-title":["Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/01.CIR.0000116202.41966.D4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T14:33:16Z","timestamp":1715005996000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/01.CIR.0000116202.41966.D4"}},"subtitle":["Should We Be Cautious?"],"short-title":[],"issued":{"date-parts":[[2004,2,17]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,2,17]]}},"alternative-id":["10.1161\/01.CIR.0000116202.41966.D4"],"URL":"https:\/\/doi.org\/10.1161\/01.cir.0000116202.41966.d4","relation":{},"ISSN":["0009-7322","1524-4539"],"issn-type":[{"value":"0009-7322","type":"print"},{"value":"1524-4539","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,2,17]]},"assertion":[{"value":"2004-01-26","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}